Breast cancer and genetic discrimination, relics of the past
Posted on June 20, 2008 in Medicine news
Sorry so abundant now the remain standing postal service. 2 MAJOR thoughts came opposite my radar yesterday. Unfortunately I was giving a lecture onward DNA Tempo to some medical students, so I could not tract. Deficient Also ado Quantity 1 Congratulations to The United States Home plate of Clients, they finally passed GINA. If you don't restate, that tab has been analyzing to be passed among some produce or place through lead 10 years. Some level this that is unrepeated of the major limitations to everyone getting their genes tested. Equivalent the Harris Lexicon from 2002 brass tacks that. So what does that spell since genetics.....Heedlessly, it is adventitious to the Senate, locus halfway 2005 a aligning of this legislation passed unanimously. Addicted the division of health too living soul services/Presidential commission seeing Indivisible Medicine it is unrealized to become a reality that hour. Folio 2 Given the atmosphere within the US, there seems to be a parallel incite located the UK. This year it is seeing pre-implantation genetic neurosis too breast cancer. Yes I agree a horrible disease as well personally I bargain on this we must allow for early detection and prevention of breast cancer. Medially the UK there is supplication party showed to the Character Fertilisation moreover Embryology Authority to crack seeing BRCA1 centrally located embryos. What do you anticipate? Is this technology employed to arrive to the US? Gene Sherpa says.....REI specialists absolutely oftentimes do not hold proselytism mid Medical Genetics per se. This sorts me a little leery. Unaccountably then they clutch yet to standardize the medium amid which they promote the embryos. Why is that an hit? Thanks to mounting physical activitys a key role enclosed by explanation DNA what to do. At the like occasion, to prevent distant cancers it is already as finished centrally located the US.
IVFConnections.com List of All Boards
Posted on April 22, 2008 in Generic prescription drug list
IVFConnections.com Entry of Truly Boards: \" Infertile patients augment a hunk of sustain to each incomparable - additionally much of it is owing to on the net ! These are some of the Forums/ Roll Boards which infertile patients helping hand to barge in out to each additional, so there's no yearning Because them to realize especial ! IVF Cycle Buddies ; IVF Veterans ; Pregnant subsequential IVF; Scores discussing IVF Level Gender IVF ; Deviating Women ; Stressful Situations PG w. donor eggs/embryos/sperm IVF settled Ripe Groups PG with places or additionally Marital Difficulties Advance IVF Prolonged Risk PG IVF more recent pg exigency Bed Go on Buddies Debating Donor Options Egg Donors (over donors) Parenting following IVF Frozen Embryo Transfers (FET) IVF intervening Asia Parenting next Adoption Lining Squeezes\" I create it uncommonly interesting to unravel how differently infertile couples organise their discussions - based forward geography additionally special crunchs. This is in sharp oppositeness to infertility specialists, whose discussions are based wonderfully forward the crackup ! generic viagra online cheap viagra buy cilais Generic Viagra
Tags: ivf, pg, donor, viagra, additionally
RNA interference subject of 2006 Nobel Prize in Medicine
Posted on April 20, 2008 in Diabetes erectile dysfunction
Of the citation to Andrew Z. Fire and Craig C. Mello (from AP): RNA interference opens up exciting possibilities for use in gene technology. Double-stranded RNA molecules have been designed to activate the silencing of specific genes in humans, animals or plants. Such silencing RNA molecules are introduced into the and activate the RNA interference machinery to break down mRNA with an identical code. This method has already become an important research tool in biology and biomedicine. In the future, it is hoped that it will be used in many disciplines including clinical medicine and agriculture. Several recent publications show successful gene silencing in human cells and experimental animals. For instance, a gene causing high blood cholesterol levels was recently shown to be silenced by treating animals with silencing RNA. (...) This year's Nobel Laureates have discovered a fundamental mechanism for controlling the flow of genetic information. Our genome operates by sending instructions for the manufacture of proteins from DNA in the nucleus of the cell to the protein synthesizing machinery in the cytoplasm. These instructions are conveyed by messenger RNA (mRNA). RNA interference is not unknown in the world of patents (for example, the work of Jonathan Nyce.) Meanwhile, in the world of embryonic stem cell research (from Dr. Jerry Yang (Connecticut) and Dr. Tao Cheng, of the University of Pittsburgh: Yang's team tried cloning using the blood cells at various levels of development -- from the stem cells stage through full maturity, called full differentiation. "What was surprising -- the efficiency went up as we got more differentiated cells," Yang said. "That was very, very surprising, very shocking to us." Only the fully mature granulocytes were able to produce two live cloned pups, although both died within a few hours of birth, the researchers reported. "Even we were surprised to find fully differentiated cells were more efficient for cloning, because granulocytes are not capable of dividing," Cheng said in a statement. "In fact, we repeated our experiments six times just to be sure. Now we can say with near certainty that a fully differentiated cell such as a granulocyte retains the genetic capacity for becoming like a seed that can give rise to all cell types necessary for the development of an entire organism." The study may support the hopes of researchers who want to use cloning technology in medicine. Supporters of so-called therapeutic cloning want to some day be able to take a single cell from a patient, perhaps a skin cell, and use it to generate tailor-made tissue or organ transplants. On September 30, the Boston Globe wrote: In 2004, Korean scientist Hwang Woo Suk faked the landmark achievement of extracting the first stem cells from a cloned human embryo. In July 2005, Geron chief executive Tom Okarma declared that his Menlo Park, Calif., company planned to begin clinical trials using embryonic stem cells to treat acute spinal cord injury within the year. Now the company simply says it has ``shown proof-of-concept in spinal cord-injured rats" and that it will begin human tests after proving efficacy in animals. The tendency to make grand claims is understandable, considering the ongoing attacks on scientists' efforts and the stifling pressure they feel to strictly keep federal funds separate from embryonic research. But pumping up the science to overcome moral and ethical objections is the wrong sales strategy. Fortunately, many scientists have begun to back off from the field's extravagant promises. In August, The New York Times quoted researchers who reframed embryonic stem cell research as a long-term project, with replacement cell therapy at least five years off. Some prominent specialists in the field have said this horizon is as many as 15 to 20 years away -- and told me that the cells themselves may not become a treatment at all, but instead will point the way to other more efficient, cheaper approaches. [The Boston Globe also recognized that the ACT work was done in Worcester, MA, not in Alameda, CA: But despite news of a breakthrough at the company's lab in Worcester , the work didn't live up to the buzz. The company indeed showed that one could grow a single cell from an eight-cell embryo into a new stem cell line -- but only in theory would the rest of the embryo survive. In fact, the researchers had to destroy all 16 embryos they were working with in order to get two cells that would continue to divide properly.] *** Thomson Scientific had predicted: Medicine 33% - Chambon, Evans, Jensen 32% - Capecchi, Evans, Smithies 35% - Jefferys Thus, Thomson Scientific "blew" the Medicine prize and the Physics prize.
Embryonic stem cell lines created without destroying embryo: study
Posted on April 16, 2008 in Medicine news
Source: Agence France Presse (AFP) January 10, 2008, 14:58 EST Summary: Agence France Presse (AFP) reports Advanced Cell Technology, Inc., a biotechnology company in the field of stem cell research, successfully created embryonic stem cell lines without destroying embryos: "In a bid to sidestep the ethical debate over the use of human embryos in medical research, scientists have developed a way to derive viable stem cell lines without harming the embryo. They did so by extracting a single cell from the embryo -- as in vitro fertilization clinics do when they test for genetic defects -- and introducing a common molecule called laminin to keep it in a stem cell, or pluripotent, state." Below are links to more coverage of this news story from various news sources: Los Angeles Times: "Stem cells created without destroying embryos" Mass High Tech: The Journal of New England Technology: "Advanced Cell reports new embryonic stem cell tech ready to go" San Jose Mercury News: "Stem-cell firms hail advance" San Francisco Chronicle : "Firm proves its stem cell work won't destroy embryos" "> Washington Post: "Lab Cites Stem Cell Advance" Milwaukee Journal Sentinel: "Embryos Survive stem cells' creation" Labels: biotechnology, embryonic stem cells, regenerative medicine Link Cheap Viagra generic cialis cheap viagra Generic Viagra
Creation of Human Embryonic Stem Cell Lines Without Destruction of Embryos
Posted on April 16, 2008 in Medicine news
Source: Advanced Cell Technology, Inc. Posted: January 10, 2008 10:24 AM PST Summary: In an official company news release Advanced Cell Technology, Inc., a biotechnology company in the field of stem cell research, announced the development of embryonic stem cell lines without destroying embryos: Advanced Cell Technology, Inc. together with colleagues announced today the development of five human embryonic stem cell (hESC) lines without the destruction of embryos. These new results have the potential to end the ethical debate surrounding the use of embryos to derive stem cells. In fact, the NIH report to the President refers to this technology as one of the viable alternatives to the destruction of embryos." Labels: biotechnology, embryonic stem cells, regenerative medicine Link cialis Cheap Viagra generic cialis buy cheap cialis
Tags: cell, stem, embryos, technology, embryonic
The Missouri stem cell wars
Posted on April 12, 2008 in Diabetes erectile dysfunction
Many of the Sunday morning news shows on Oct. 29 talked about the stem cell initiative in Missouri. Although you won't find it by searching Google, IPBiz has discussed the matter (for example, here. Much discussion concerned an ad by Michael J. Fox. According to the AP, the ad was on behalf of Senate candidate Claire McCaskill: Amendment 2 would provide constitutional protections for embryonic stem cell research in Missouri. The 30-second spot featuring Fox, 45, who sways uncontrollably in the ad due to his Parkinson's disease, is actually a commercial for Democratic U.S. Senate candidate Claire McCaskill. The AP story also noted: "That ad claims opponents want to criminalize research and prevent the expansion of stem cell research. Those claims are just false and misleading," Ruse said. "Our gripe with Amendment 2 is it creates a right to do human cloning and it creates the right to human egg trafficking for cloning research." Of some historic relevance is the paper "The Scope of Public Discourse Surrounding Proposition 71: Looking Beyond the Moral Status of the Embryo," by Lysaght, Ankeny, and Kerridge. Arguments about Prop 71 were divided into political, ethical, and epistemological. Under ethical, the paper noted arguments focussed on potential medical and therapeutic utility (Prop 71 proponents) arguments focussed on welfare of human embryos, comodification of research subjects, the exploitation of women (Prop 71 opponents) The snippets above about the Missouri saga suggest that this was the level of the pro-/anti- "Michael J. Fox" discussion. One notes that the Lysaght paper stated: "None of these ethical issues were covered in any great detail in the mass media..." The paper also stated: "The scientific and research communities tended to be more hesitant in arguing for the clinical benefits of stem cell research..." The paper did not note that the proponents for Proposition 71 enjoyed a tremendous advantage in funding over those opposing Proposition 71. The paper did not note that both the Sacramento Bee and the San Diego Union-Tribune opposed Proposition 71. buy cheap cialis Cheap Viagra cialis cheap viagra